Increased geriatric population and growing awareness among people about the Alzheimer’s disease to drive global dementia and alzheimer’s disease treatment market
According to TechSci Research report, “Global Dementia and Alzheimer’s Disease Treatment Market By Drug Class, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2025”, Global dementia and alzheimer’s disease treatment market is estimated to witness significant CAGR during the forecast period. Increasing prevalence of AD worldwide is one of the major factors accounting for the growth of global dementia and alzheimer’s disease treatment market. Moreover, advances in diagnostic capabilities is expected to bode well for the growth of global dementia and alzheimer’s disease treatment market through the forecast period. In addition to this, mounting cases of mild cognitive impairment across the globe is positively influencing the growth of global dementia and alzheimer’s disease treatment market. Also, growing awareness and development of newer therapies with maximum therapeutic effects, is making headway for the growth of global dementia and alzheimer’s disease treatment market. Furthermore, investment in biomarkers for drug development is also contributing to increasing market growth. However, there are certain factors that might hamper the growth of global dementia and alzheimer’s disease treatment market over the coming years such as high cost of advanced treatments and severe side-effects associated with certain treatments such as nausea, insomnia, diarrhea, fatigue and anorexia.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “ Global Dementia and Alzheimer’s Disease Treatment Market “
https://www.techsciresearch.com/report/dementia-and-alzheimers-disease-treatment-market/5058.html
Global dementia and alzheimer’s disease treatment market can be segmented based on drug class, distribution channel, company, and region. Considering the distribution channel, the market is fragmented into hospital pharmacies, retail pharmacies and online pharmacies. Among these, the hospital pharmacies segment dominated the global dementia and alzheimer’s disease treatment market in terms of largest market share until 2019 and is further anticipated to maintain its dominance during the forecast period as well which can be accredited to availability of cheap and cost effective medicines at pharmacies in hospitals for the treatment of AD. Moreover, enhanced safety of replacement therapy by using recombinant factor concentrates, is further boosting the segmental growth. Also, the online pharmacies segment is anticipated to rise at a considerable CAGR during the next 5 years, which is attributed to the presence of considerable discounts online coupled with easy availability of drugs at home. Moreover, for long-term treatment required for the treatment of alzheimer’s disease, buying through online pharmacies is preferred, which is boosting the segmental growth.
Merz Pharma GmbH & Co. KGaA, Novartis AG, Allergan plc., Pfizer, Inc., Daiichi Sankyo Company, Limited, Ono Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Eisai Co., Ltd., H. Lundbeck A/S, F. Hoffmann-La Roche Ltd., AbbVie Inc., Eli Lilly and Company, Biogen, INmuneBIO, AstraZeneca among others are the leading players operating in global dementia and alzheimer’s disease treatment market. The leading players are adopting several growth strategies to enhance the market scenario of dementia and alzheimer’s disease treatment. Other competitive strategies include mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diverse their product portfolio in order to strengthen their market position.
download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5058
customers can also request for 10% free customization on this report.
“North America is forecast to dominate the global dementia and alzheimer’s disease treatment market until 2025 on account of high awareness regarding alzheimer’s disease in the region. Furthermore, growing requirement for advanced therapies along with disease modifying drugs are also contributing to the growing trend. Additionally, improving health care infrastructure in the region is anticipated to bolster the growth of global dementia and alzheimer’s disease treatment market over the coming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Dementia and Alzheimer’s Disease Treatment Market By Drug Class, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global dementia and alzheimer’s disease treatment market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global dementia and alzheimer’s disease treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
